Analyzing blood clotting in hospitalized COVID-19 patients with severe pneumonia

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to investigate the relationship between hemostasis and inflammation in hospitalized patients suffering from COVID-19 and severe pneumonia. By utilizing venous ultrasound and blood samples, the study will assess the coagulation status and the risk of thromboembolic events in these patients. The research seeks to enhance understanding of how COVID-19 may increase the likelihood of blood clots, contributing to better management of complications associated with the disease.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* all patients hospitalized in Amiens Hospital with COVID-19 infection

Exclusion Criteria:

* patients\< 18 years

Where it's running

• CHU Amiens
  Amiens, France Recruiting

Study contacts

• Principal investigator: Michel Slama, Pr — CHU Amiens
• Study coordinator: Michel Slama, Pr
• Email: slama.michel@chu-amiens.fr
• Phone: (33)3 22 08 78 41

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Comparative Immunogenicity of Respiratory Virus Vaccines (CIRV2) in Adults

  This study tests and compares the immune responses and tolerability of the latest COVID-19 vaccines from Novavax and Pfizer/BioNTech in adults at risk for severe COVID-19.

  Recruiting Phase 4 Henry M. Jackson Foundation for the Advancement of Military Medicine · Bethesda, Maryland · NCT07287137

• Omicron-based COVID-19 vaccine with Matrix-M given as a single dose in older adults and high-risk individuals

  A single-dose Omicron-subvariant vaccine with Matrix-M is tested to see if it is safe and can induce an immune response in adults 65+ and in younger adults with conditions that raise the risk of severe COVID-19, who were previously vaccinated.

  Recruiting at 20 sites Phase 4 Sanofi · Fair Oaks, California and 19 other locations · NCT07861542

• NasoAid vs NasoPore after Nasal Surgery

  This study tests whether collagen-based NasoAid® nasal packing works as well as the synthetic NasoPore for stopping bleeding after nasal surgery in adults.

  Recruiting at 2 sites Maxigen Biotech Inc. · Taipei and 2 other locations · NCT07861061

• Bleeding control after single-ray amputation: Hemocoll vs Avitene vs bone wax

  This trial tests whether Hemocoll, Avitene, or bone wax better stop bleeding from exposed bone after a planned single-ray amputation in adults.

  Recruiting at 3 sites Adichunchanagiri Institute of Medical Sciences, B G Nagara · Kolār, Karnataka and 2 other locations · NCT07788846

• Secutrelvir for nonhospitalized COVID-19 in teens and adults

  This study tests whether secutrelvir can help nonhospitalized people with COVID-19 see faster symptom relief compared with a placebo.

  Recruiting Phase 3 Shionogi Inc. · Multiple Locations · NCT07746544

• Appropriateness of Hemostatic Agent Use in Cardiovascular Surgery

  This study tests how well surgeons’ choices about topical hemostatic agents match current guidelines in cardiac and vascular surgery at one Milan hospital.

  Recruiting University of Milan · Milan, MI · NCT07699016

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.